Susan G. Komen®
About Susan G. Komen®
Susan G. Komen has led the fight to create a world without breast cancer for nearly four decades throughout our communities. We remain steadfast in our mission to save lives by meeting the most critical needs in our local communities and investing in breakthrough research to prevent and cure breast cancer. We are actively working to drive change through spearheading public policy and advocacy, eliminating racial barriers and inequities in health care, discovering breakthrough treatments, and providing direct support for patients in need.
Programs & Services Offered
The Susan G. Komen Breast Care Helpline provides information about breast health, breast cancer, local and national resources, and information about clinical trials. Call 1-877-465-6636 or email helpline@komen.org.
The Breast Care Helpline offers: Breast health and breast cancer information
Emotional support to anyone with questions or concerns
Information about Komen’s Treatment Assistance and Patient Navigation programs
Information about national and local organizations and resources that may provide financial assistance and other support services, including low-cost mammography
Our Helpline Specialists are available to breast cancer patients, their loved ones, health care providers, support professionals and all others seeking breast health information. We can help:
Connect you to needed services, resources, and information
Discuss your feelings and provide guidance in addressing them
You learn more about support and coping mechanism
Coach you on communicating with your health care team
Friends and family provide and receive emotional support
Komen Financial Assistance Program
Komen Financial Assistance Program is eligible to individuals undergoing breast cancer treatment at any stage or living with metastatic breast cancer (stage IV), the most advanced stage of breast cancer.
Financial assistance is available to those who meet pre-determined eligibility criteria. To learn more about this program and other helpful resources, call the Komen Breast Care Helpline at 1-877 GO KOMEN (1-877-465-6636) or email helpline@komen.org.
Clinical Trials
The Breast Care Helpline also offers breast cancer clinical trial education and support, such as:
· Knowing when to consider a clinical trial
· How to find a clinical trial
· How to decide which clinical trial is best
· What to expect during a clinical trial
· Information about clinical trial resources
Susan G. Komen is committed to disability access, equal opportunity, and reasonable accommodation. To request accommodation, contact helpline@komen.org or 1-877-465-6636.
To hear from one of our helpline specialists, read Komen’s blog – “From Hopelessness to Hope”.
Did You Know
Together, we’ve made great progress:
Through early detection and effective treatments, we’ve helped reduce the breast cancer mortality rate in the U.S. by 42% since 1989
Komen’s research investments helped develop all 19 new lifesaving, FDA-approved breast cancer drugs in the past decade.
In the last year alone, we provided more than $11 million in financial assistance and 52,000 crucial services to more than 38,000 patients across the country through Komen’s Patient Care Center.
We’ve invested nearly $1.1 billion in research, leading to new ways to prevent, detect, diagnose and treat breast cancer.
Komen is the only dedicated breast cancer organization serving as a nonpartisan voice for more than 4 million breast cancer survivors in the U.S. on Capitol Hill and in all 50 states, empowering people and policymakers with knowledge, connecting advocates together and mobilizing everyone to act for lasting change.
Yet despite all our progress:
Breast cancer is still the most common cancer in women worldwide and the second leading cause of cancer death among women in the U.S.
Every 2 minutes, somewhere in the U.S., a woman is diagnosed with breast cancer.
It’s estimated that more than 168,000 people in the U.S. are living with metastatic breast cancer (MBC), which is the most advanced stage of breast cancer.
Nearly 43,000 people in the U.S. are expected to die from metastatic breast cancer this year alone.
Black women are about 40 percent more likely to die of breast cancer than white women and have a lower five-year relative breast cancer survival rate compared to white women.
You Can Help
$20 per month helps fund an annual mammogram.
$50 helps a breast cancer patient with transportation assistance to screening, diagnostic or treatment appointments.
$100 gives someone the opportunity to participate in an 8-week survivorship support education class.
$250 gives an uninsured woman access to various screening or diagnostic procedures.
$500 is the average cost of core-needle biopsy for someone without insurance.
Dollars at Work
On average, 728 people in Nebraska seek help and information from Susan G. Komen every week throughout 93 Counties across the state.
In FY24, Komen Financial Assistance Program provided Nebraska and Iowa residents over $121,000 in financial assistance for the expenses of daily living for people in breast cancer treatment or living with MBC.
Komen’s Patient Care Center provided 44,789 services to 37,970 people living in the U.S. , working to address 56,212 barriers to care that may otherwise prevent someone from getting the breast health care or support they need. Services provided include emotional support, breast health or breast cancer information, access to screening and diagnostic services, financial assistance and more.
Komen’s research investment contributed to the development of all 19 lifesaving breast cancer drugs approved by the FDA over the past 12 years. These drugs are being used to treat early-stage and advanced/metastatic breast cancers of all types, including hormone receptor-positive, HER2-positive, and triple negative breast cancers.
ShareForCures launched; a breast cancer registry for researchers with information from people who have or had breast cancer to help discover cures for breast cancer, faster.
Contact Info
Jennifer Redmond - State Executive Director, Nebraska | 402-251-5355 | jredmond@komen.org | website